Succinylcholine Chloride Injection, Solution
Product Images NDC 68083-450

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Succinylcholine Chloride (NDC 68083-450). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Succinylcholine Chloride Spl Carton Label

Succinylcholine Chloride Spl Carton Label
This is a product description for Succinylcholine Chloride Injection, a paralyzing agent used for intravenous or intramuscular use. It is stored in 10 mL vials in a refrigerator and requires aseptic technique for use. It contains Succinylcholine chloride, methylparaben, and propylaraben as preservatives, and sodium chloride to achieve isotonicity. The solution must be clear, non-pyrogenic, and without damage. The text provides additional instructions and warnings, such as respiratory arrest risk and the requirement for immediate availability of artificial respiration facilities. The product is manufactured by Gland Pharma Limited in Hyderabad, India.*
FDA Label Image

Succinylcholine Chloride Spl Sticker Label

Succinylcholine Chloride Spl Sticker Label
This text is a label of a drug called Succinylcholine Chloride Injection, USP. It is a paralyzing agent that should only be used in a specific setting, such as an operating suite. The remaining text appears to be non-English and may be a result of errors in .*
FDA Label Image

Succinylcholine Chloride Spl Structure

FDA Label Image

Succinylcholine Chloride Spl Vial Label

Succinylcholine Chloride Spl Vial Label
This is a description for an injectable solution with a 20mg/mL concentration of Succinylcholine Chloride. The solution, manufactured by Gland Pharma Limited, contains preservatives such as 0.18% methylparaben and 0.02% propylparaben, and must be stored at 2° to 8°C. This is a sterile, nonpyrogenic medication that requires aseptic technique. The solution is suitable for intravenous or intramuscular use and caution should be taken as it is a paralyzing agent that can cause respiratory arrest. Facilities for artificial respiration need to be immediately available. Batch details are included for tracking.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.